The Microrna Let-7 and Its Exosomal Form: Epigenetic Regulators of Gynecological Cancers Publisher Pubmed



Wang F¹ ; Zhou C¹ ; Zhu Y¹ ; Keshavarzi M²
Source: Cell Biology and Toxicology Published:2024

Abstract

Many types of gynecological cancer (GC) are often silent until they reach an advanced stage, and are therefore often diagnosed too late for effective treatment. Hence, there is a real need for more efficient diagnosis and treatment for patients with GC. During recent years, researchers have increasingly studied the impact of microRNAs cancer development, leading to a number of applications in detection and treatment. MicroRNAs are a particular group of tiny RNA molecules that regulate regular gene expression by affecting the translation process. The downregulation of numerous miRNAs has been observed in human malignancies. Let-7 is an example of a miRNA that controls cellular processes as well as signaling cascades to affect post-transcriptional gene expression. Recent research supports the hypothesis that enhancing let-7 expression in those cancers where it is downregulated may be a potential treatment option. Exosomes are tiny vesicles that move through body fluids and can include components like miRNAs (including let-7) that are important for communication between cells. Studies proved that exosomes are able to enhance tumor growth, angiogenesis, chemoresistance, metastasis, and immune evasion, thus suggesting their importance in GC management. Graphical Abstract: Impact of let-7 on female malignancies and diseases of the female reproductive tract. Let-7 expression is dysregulated in a variety of gynaecological and obstetric disorders. (Figure presented.). © The Author(s) 2024.